June 4, 2026 – The U.S. Food and Drug Administration (FDA) has authorized four additional Glas G2 refill pods, including blueberry and mango varieties, expanding the agency’s list of legally marketed vaping products in the United States.
The newly authorized pods are available exclusively in a nicotine strength of 50 mg/mL and represent one of the few non-tobacco flavored vaping products to receive marketing authorization under the FDA’s Premarket Tobacco Product Application (PMTA) pathway.
The decision further expands the FDA-authorized vaping market, which remains relatively limited compared to the broader range of products available globally.
What Was Authorized?
The latest authorization adds four Glas G2 refill pods to the FDA’s roster of authorized electronic nicotine delivery systems (ENDS). The Glas G2 product line now includes:
- One tobacco-flavored pod
- Two menthol-flavored pods
- Two fruit-flavored pods (Blueberry and Mango)
The authorization follows the FDA’s March 2026 decision granting marketing orders for the Glas G2 device and its Blonde Tobacco refill pod.
While tobacco and menthol products continue to dominate the FDA’s authorized portfolio, the addition of fruit-flavored options marks a notable development in the agency’s review process.
Current FDA-Authorized E-Liquid Vapes
As of June 2026, the following vaping products have received FDA marketing authorization and remain available for sale in the United States:
Glas G2
- Device
- One tobacco-flavored pod
- Two menthol-flavored pods
- Two fruit-flavored pods
JUUL
- Device
- Virginia Tobacco pods
- Menthol pods
- Available in 3% and 5% nicotine strengths
Logic Pro
- Device
- Two tobacco-flavored refill cartridges
Logic Power
- Device
- One tobacco-flavored refill cartridge
NJOY DAILY
- Tobacco version
- Menthol version
NJOY DAILY EXTRA
- Tobacco version
- Menthol version
NJOY ACE
- Device
- Three tobacco-flavored pods
- Two menthol-flavored pods
Vuse Alto
- Device
- Six tobacco-flavored refill pods
Vuse Solo
- Device
- Two tobacco-flavored refill cartridges
Vuse Vibe
- Device
- One tobacco-flavored refill cartridge
Recent FDA Vape Authorizations
The FDA’s authorized vaping portfolio has expanded gradually over the past two years.
In June 2024, the agency authorized four menthol-flavored products manufactured by NJOY, including NJOY ACE Menthol pods and menthol versions of the NJOY DAILY and DAILY EXTRA devices.
One month later, in July 2024, the FDA granted marketing authorization to the Vuse Alto device and six tobacco-flavored refill pods. In July 2025, the agency authorized the JUUL device alongside Virginia Tobacco and Menthol pods in both 3% and 5% nicotine strengths.
Most recently, the FDA authorized the Glas G2 device in March 2026 before expanding the lineup with additional menthol and fruit-flavored pods in June.
What FDA Authorization Means
FDA marketing authorization allows a tobacco product to be legally marketed in the United States. However, authorization does not mean a product is safe, nor does it mean the product has been “FDA approved.”
According to the agency, all tobacco and nicotine products carry health risks and may cause addiction. To receive authorization, manufacturers must demonstrate that marketing a product would be “appropriate for the protection of public health.”
The FDA evaluates scientific evidence, product characteristics, toxicological data, and the potential impact on both adult smokers and youth before issuing a marketing order.
The agency maintains an online list of authorized e-cigarettes and updates it whenever new products receive authorization.
Newly authorized products are also added to the FDA’s Searchable Tobacco Products Database, which serves as the agency’s most comprehensive record of legally marketable tobacco products.
A Small Slice of the Vape Market
Although the FDA has authorized dozens of vaping products, the list remains relatively narrow compared to the broader U.S. vaping market.
Most authorized products fall into tobacco or menthol categories, while many popular product segments-including bottled e-liquids, open-system devices, refillable tank systems, and a large number of disposable vapes-have yet to receive marketing authorization.
At the same time, numerous PMTAs remain under FDA review, and some manufacturers continue to challenge marketing denial orders in federal court.
As a result, the FDA’s authorized product list represents only part of the evolving regulatory landscape surrounding vaping products in the United States.
Looking Ahead
The authorization of four additional Glas G2 pods signals continued movement within the FDA’s PMTA review process and modest growth in the agency’s authorized vaping portfolio.
While tobacco and menthol products still dominate the market, the addition of blueberry and mango pods suggests that the range of authorized products may gradually expand beyond traditional flavor categories.
With applications from multiple manufacturers still awaiting regulatory decisions, the FDA’s list of authorized vaping products is likely to continue evolving throughout 2026.
Sources: U.S. Food and Drug Administration (FDA), FDA Marketing Granted Orders (MGOs), FDA Searchable Tobacco Products Database.
Vapor Insight independently reviews regulatory developments affecting the vaping and nicotine industries. This article is based on publicly available FDA records and agency communications available at the time of publication.